- Stocks
- Healthcare
- NYSE: SYK

Price (delayed)

$263.92

Market cap

$99.29B

P/E Ratio

61.95

Dividend/share

$2.41

EPS

$4.26

Enterprise value

$110.33B

Stryker Corporation is an American multinational medical technologies corporation based in Kalamazoo, Michigan. Stryker's products include implants used in joint replacement and trauma surgeries; surgical equipment and surgical navigation systems;

SYK's equity is up by 2.2% year-on-year

SYK's P/E is 70% above its 5-year quarterly average of 36.4 and 44% above its last 4 quarters average of 43.2

SYK's quick ratio is down by 44% from the previous quarter and by 31% YoY

What are the main financial stats of SYK

Market
Valuations
Earnings

Shares outstanding

376.2M

Market cap

$99.29B

Enterprise value

$110.33B

Price to earnings (P/E)

61.95

Price to book (P/B)

7.58

Price to sales (P/S)

6.91

EV/EBIT

56.47

EV/EBITDA

48.1

EV/Sales

7.69

Revenue

$14.35B

EBIT

$1.95B

EBITDA

$2.29B

Free cash flow

$2.79B

Per share
Balance sheet
Liquidity

EPS

$4.26

Free cash flow per share

$7.43

Book value per share

$34.82

Revenue per share

$38.22

TBVPS

$42.6

Total assets

$34.33B

Total liabilities

$21.25B

Debt

$13.99B

Equity

$13.08B

Working capital

$4.67B

Debt to equity

1.07

Current ratio

1.93

Quick ratio

1.14

Net debt/EBITDA

4.82

Margins
Efficiency
Dividend

EBITDA margin

16%

Gross margin

63.1%

Net margin

11.1%

Operating margin

15.5%

Return on assets

5%

Return on equity

12.3%

Return on invested capital

9.6%

Return on capital employed

6.7%

Return on sales

13.6%

Dividend yield

0.91%

DPS

$2.41

Payout ratio

56.6%

How has the Stryker stock price performed over time

Intraday

-0.09%

1 week

2.64%

1 month

15.03%

1 year

44.63%

YTD

7.7%

QTD

8.35%

How have Stryker's revenue and profit performed over time

Revenue

$14.35B

Gross profit

$9.06B

Operating income

$2.22B

Net income

$1.6B

Gross margin

63.1%

Net margin

11.1%

SYK's net income is down by 23% year-on-year and by 9% since the previous quarter

SYK's net margin is down by 21% YoY and by 10% from the previous quarter

The operating income has declined by 18% year-on-year and by 8% since the previous quarter

Stryker's operating margin has decreased by 15% YoY and by 9% QoQ

What is Stryker's growth rate over time

What is Stryker stock price valuation

P/E

61.95

P/B

7.58

P/S

6.91

EV/EBIT

56.47

EV/EBITDA

48.1

EV/Sales

7.69

SYK's P/E is 70% above its 5-year quarterly average of 36.4 and 44% above its last 4 quarters average of 43.2

Stryker's EPS has decreased by 24% YoY and by 9% from the previous quarter

SYK's P/B is 33% above its 5-year quarterly average of 5.7 and 31% above its last 4 quarters average of 5.8

SYK's equity is up by 2.2% year-on-year

The stock's price to sales (P/S) is 44% more than its 5-year quarterly average of 4.8 and 33% more than its last 4 quarters average of 5.2

The company's revenue fell by 3.6% YoY

How efficient is Stryker business performance

Stryker's ROIC has decreased by 36% YoY and by 15% from the previous quarter

The ROA has contracted by 34% YoY and by 12% from the previous quarter

The ROE fell by 28% YoY and by 10% QoQ

Stryker's ROS has decreased by 21% YoY and by 13% from the previous quarter

What is SYK's dividend history

DPS

$2.41

Dividend yield

0.91%

Payout ratio

56.6%

Recent dividends

How did Stryker financials performed over time

The total assets is 62% greater than the total liabilities

SYK's quick ratio is down by 44% from the previous quarter and by 31% YoY

The current ratio has declined by 33% since the previous quarter and by 23% year-on-year

SYK's debt is 7% more than its equity

SYK's debt is up by 26% YoY and by 7% from the previous quarter

The debt to equity has grown by 23% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.